CompletedPhase 3Phase 4ACTRN12605000373673

A Trial of Pre-Quitting Nicotine Replacement Therapy

A single blind randomised controlled trial comparing the use of Nicotine Replacement Therapy (NRT) while still smoking for 2 weeks prior to quitting followed by usual NRT practice, with usual NRT cessation practice on smoking abstinence at 6 months.


Sponsor

Health Research Council (NZ)

Enrollment

1,100 participants

Start Date

Mar 6, 2006

Study Type

Interventional

Conditions


Eligibility

Sex: Both males and femalesMin Age: 18 Yearss

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying A Trial of Pre-Quitting Nicotine Replacement Therapy. It may be open to adults aged 18 and older. Participation typically involves regular medical visits, tests, and following the study's treatment plan.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

The study is a single blind randomised controlled trial of Nicotine replacement therapy (HABITROL: patches and/or gum)while still smoking for two weeks prior to Quit Day followed by usual practice, ve

The study is a single blind randomised controlled trial of Nicotine replacement therapy (HABITROL: patches and/or gum)while still smoking for two weeks prior to Quit Day followed by usual practice, versus usual practice. Usual practice comprises an 8 week programme of NRT patches and or gum and support calls (eg Quitline) or face to face visits for other cessation providers (eg Aukati Kai Paipa), commencing on Quit Day.


Locations(1)

New Zealand

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12605000373673


Related Trials